School of Medicine
Showing 421-440 of 1,580 Results
-
Pankaj Gupta
Postdoctoral Scholar, Neurosurgery
BioPankaj Gupta is a postdoctoral researcher at Stanford University working at the intersection of systems neuroscience, neuroengineering, and computational modeling. His research focuses on understanding how distributed neural circuits generate behavior and how these circuits reorganize during learning and recovery, particularly in the context of motor control and neurological disorders such as stroke.
Pankaj completed his Ph.D. at the University of British Columbia, where he investigated brain–behavior dynamics using widefield and two-photon calcium imaging in mice. His work combined experimental neuroscience with real-time closed-loop systems, enabling the modulation of neural activity through behaviorally contingent feedback. He also developed computational tools and biologically inspired recurrent neural network models to capture large-scale neural dynamics and inter-regional interactions.
At Stanford, his research expands to include large-scale electrophysiology using Neuropixels probes to study cerebellar and subcortical circuits involved in motor control and recovery. He is particularly interested in how neural populations across multiple brain regions coordinate and adapt following injury, and how these insights can inform the design of closed-loop neurostimulation and brain–machine interface systems. -
Shreya Gupta
Postdoctoral Scholar, Cardiovascular Medicine
Current Research and Scholarly InterestsI am a biomedical researcher focused on understanding the molecular mechanisms governing vascular smooth muscle cell (SMC) behavior in cardiovascular and metabolic diseases. My work investigates how signaling pathways, including Notch3 and Thrombospondin-1, regulate SMC phenotypic switching, fibrous cap stability, and plaque vulnerability in atherosclerosis, with the goal of identifying novel therapeutic targets to prevent heart attacks and strokes.
-
Edward Guzman
Postdoctoral Scholar, Cardiovascular Medicine
BioEdward Guzman is a postdoctoral fellow in cardiovascular medicine at Stanford University. He earned his Ph.D. from Harvard University in collaboration with the Massachusetts Institute of Technology (MIT), focusing on RNA treatments for vascular diseases. His research has advanced the development of novel cardiovascular therapies and deepened our understanding of endothelial cell biology under diseased conditions.
-
Richard Haarburger
Postdoctoral Scholar, General Internal Medicine
BioRichard Haarburger is a postdoctoral scholar in the Department of Medicine (Primary Care and Population Health) at Stanford University, working in the lab of Pascal Geldsetzer. He studies questions at the intersection of epidemiology, health policy, and applied econometrics, with a focus on causal inference in large real-world health datasets.
His current work uses quasi-experimental and survival analysis methods to evaluate how preventive interventions (e.g. herpes zoster vaccinations) affect neurological outcomes such as dementia incidence at the population level. He also develops empirical strategies for dealing with challenges common in observational health data, including treatment effect heterogeneity, incomplete outcome follow-up, and competing risks.
Richard’s broader research interests include impact evaluation methods, causal machine learning, and the health and economic consequences of new technologies. During his PhD in quantitative economics, he worked on measurement bias in health surveys, high-dimensional forecasting, and heterogeneity in technology adoption. -
Jen Haensel
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
BioI am a Research Scientist in the Roberts Vision Development & Oculomotor Lab at Stanford University’s Department of Ophthalmology, working at the intersection of vision science, neuroscience, and experimental psychology. My current research uses eye-tracking, photorefraction, and psychophysics to study oculomotor development and visual function in amblyopia, strabismus, and concussion. I also work on developing methodology to record accommodative measurements and gaze behaviour in dynamic, naturalistic settings.
I completed my PhD in Experimental Psychology at Birkbeck, University of London (UK), where I used advanced eye-tracking techniques to study the influence of postnatal experience on social gaze behaviour. Prior to joining Stanford, I also worked as a postdoctoral researcher at the University of Bath (UK), developing empirical human-robot interaction studies to inform the ethical design of humanoid robots. -
Meghan Halley
Assistant Professor (Research) of Pediatrics (Stanford Center for Biomedical Ethics)
BioMeghan Halley, PhD, MPH is Assistant Professor of Pediatrics (Research) in the Center for Biomedical Ethics at Stanford University School of Medicine. With training in medical anthropology, public health and health services research, her scholarship draws on multidisciplinary theoretical and methodological approaches to examine ethical, legal, social and policy questions arising in clinical and translational research. Her areas of expertise include the ethics of new genomic technologies, normative frameworks for integrating research and clinical care, challenges and opportunities in patient and community engagement, and the epistemic and ethical implications of valuing new health interventions. Her work has been funded by the National Institutes of Health, the Patient Centered Outcomes Research Institute, and the National Science Foundation and published in high-impact journals including the New England Journal of Medicine, Nature Genetics, and the American Journal of Bioethics.
-
Dina Hany
Postdoctoral Scholar, Biomedical Data Sciences
BioI am currently a postdoctoral researcher in the laboratory of Prof. Sylvia Plevritis, Department of Biomedical Data Sciences. My current work involves establishing drug testing platforms to evaluate tumor drug responses with respect to the tumor microenvironment and the its spatial organization. I hold a Ph.D. in Life Sciences (Pharmaceutical Sciences) from the University of Geneva, Switzerland, where I conducted research in Prof. Didier Picard's laboratory from 2017 to 2022. Prior to that, I earned a Master’s degree in Pharmacology and Experimental Therapeutics from Alexandria University, Egypt, and a Bachelor’s degree in Pharmacy with honors from Pharos University. My professional experience includes postdoctoral research in molecular pharmacology at UNIGE and a lecturer position in Pharmacotherapeutics and Cancer Biology at Pharos University. I have extensive teaching experience, supervising undergraduate and postgraduate courses, and have successfully guided master's thesis projects. My research has focused on endocrine resistance in breast cancer, utilizing CRISPR/Cas9 screens and exploring drug combinations, resulting in several relevant publications. I have presented my work at numerous conferences and received several awards, including the Ernst et Lucie Schmidheiny Fondation grant and the Ph.D. Booster prize from the faculty of medicine, Geneva, Switzerland. I am an active member of the Life Sciences Switzerland (LS2) and the European Association of Cancer Research (EACR).
-
Prashant Hariharan
Postdoctoral Scholar, Neurosurgery
BioPrashant Hariharan is a biomedical engineer specializing in the design of "fit-for-purpose" in vitro models to study neurological disorders. He earned his B.E. from the University of Mumbai, an M.S. from the University of Texas at Arlington, an M.Eng. from Cornell University and a PhD from Wayne State University. His doctoral work with Dr. Carolyn A. Harris focused on developing an "organ-chip" model of the choroid plexus to study how cerebrospinal fluid secretion is affected by hydrocephalus. As a postdoctoral scholar in the Fame lab, Prashant is adding new layers of physiological complexity to his previous model to investigate how the body’s circadian clock regulates choroid plexus-driven cerebrospinal fluid production and composition. This work aspires to deliver model-driven insights that can be translated into CSF-centric therapies and ultimately advance the pursuit of precision medicine for brain health.
